Similar articles

• [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].

  Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC. Postma MJ, et al. Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):677-81. Ned Tijdschr Geneeskd. 1999. PMID: 10321301 Dutch.
• [Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].

  Postma MJ, Welte R, van den Hoek JA, Jager JC, van Doornum GJ, Coutinho RA. Postma MJ, et al. Ned Tijdschr Geneeskd. 1999 Nov 20;143(47):2383-5. Ned Tijdschr Geneeskd. 1999. PMID: 10590778 Dutch.
• The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.

  Gift TL, Gaydos CA, Kent CK, Marrazzo JM, Rietmeijer CA, Schillinger JA, Dunne EF. Gift TL, et al. Sex Transm Dis. 2008 Nov;35(11 Suppl):S66-75. doi: 10.1097/OLQ.0b013e31818b64ac. Sex Transm Dis. 2008. PMID: 18830137
• Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.

  van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. van Valkengoed IG, et al. Int J Epidemiol. 2004 Apr;33(2):416-25. doi: 10.1093/ije/dyh029. Int J Epidemiol. 2004. PMID: 15082651 Review.
• Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.

  Land JA, Van Bergen JE, Morré SA, Postma MJ. Land JA, et al. Hum Reprod Update. 2010 Mar-Apr;16(2):189-204. doi: 10.1093/humupd/dmp035. Epub 2009 Oct 14. Hum Reprod Update. 2010. PMID: 19828674 Review.